Patents Assigned to EUPHARMA PTY LTD
-
Patent number: 11241453Abstract: The present invention is predicated on the realisation that problems with the poor water solubility of arsenic trioxide and the extreme difficulty in dissolving arsenic trioxide in anything other than a very basic solution, could be overcome by forming a much more soluble diarsenic tetraoxide, including the compound NaHAs2O4, prior to its delivery to a patient. Pharmaceutical compositions with such compounds and their use in the treatment of cancers is disclosed.Type: GrantFiled: August 2, 2017Date of Patent: February 8, 2022Assignee: Eupharma Pty LtdInventor: Malvin Eutick
-
Patent number: 10596102Abstract: The present invention relates to an emollient composition comprising emu oil, jojoba oil, a dermatological base and a metal or metalloid oxide, hydroxide or carbonate. The composition has efficacy in the prevention or treatment of a range of skin conditions.Type: GrantFiled: August 4, 2016Date of Patent: March 24, 2020Assignee: EUPHARMA PTY LTD.Inventor: Alec Eutick
-
Patent number: 10493099Abstract: A pharmaceutical composition is provided comprising a highly soluble arsenic carbonate and/or bicarbonate compound and which is useful in the treatment of a variety of cancers, including acute promyelocytic leukaemia. The arsenic carbonate and/or bicarbonate salt acts as a solid, and so orally deliverable, improved bioequivalent delivery form of arsenic trioxide IV solutions.Type: GrantFiled: January 29, 2016Date of Patent: December 3, 2019Assignee: EUPHARMA PTY LTDInventor: Malvin Eutick
-
Patent number: 10160735Abstract: A process for the purification of diaminophenothiazinium compounds, and particularly of methylene blue, is described. The process provides for simple and effective purification by reduction of the post-synthesis or commercially available diaminophenothiazinium compound to form a reduced complex thereof. This can then be purified in a more straightforward manner than the original compound by, for example, recrystallization before being allowed to oxidize back to the diaminophenothiazinium compound.Type: GrantFiled: June 6, 2017Date of Patent: December 25, 2018Assignee: Eupharma Pty LtdInventor: Malvin Eutick
-
Publication number: 20180207086Abstract: The present invention relates to an emollient composition comprising emu oil, jojoba oil, a dermatological base and a metal or metalloid oxide, hydroxide or carbonate. The composition has efficacy in the prevention or treatment of a range of skin conditions.Type: ApplicationFiled: August 4, 2016Publication date: July 26, 2018Applicant: EUPHARMA PTY LTD.Inventor: Alec EUTICK
-
Publication number: 20180021373Abstract: The present invention relies on the hitherto unrealised high affinity binding of ruthenium and indium to gastrins. Particularly, these metals can be bound directly to the gastrins under mild conditions and so can be used in treatment of conditions associated with elevated gastrin levels and in detection of tumours and other conditions where CCK receptors are over expressed.Type: ApplicationFiled: February 4, 2016Publication date: January 25, 2018Applicant: Eupharma Pty LtdInventor: Malvin EUTICK
-
Patent number: 9701648Abstract: A process for the purification of diaminophenothiazinium compounds, and particularly of methylene blue, is described. The process provides for simple and affective purification by reduction of the post-synthesis or commercially available diaminophenothiazinium compound to form a reduced complex thereof. This can then be purified in a more straightforward manner than the original compound by, for example, recrystallization before being allowed to oxidize back to the diaminophenothiazinium compound.Type: GrantFiled: August 15, 2014Date of Patent: July 11, 2017Assignee: Eupharma Pty LtdInventor: Malvin Eutick
-
Patent number: 9522214Abstract: A method of promoting haemostasis in a patient is provided by the administration, to the site of blood loss, of a viscous thixotropic haemostatic composition comprising an ionic precipitating agent, a fatty alcohol, an alcohol phosphate diester and one of an alkoxyether phosphate or a monoester phosphate of an alkoxylated fatty alcohol.Type: GrantFiled: September 12, 2013Date of Patent: December 20, 2016Assignee: Eupharma PTY LTDInventor: Malvin Eutick
-
Publication number: 20150238652Abstract: A method of promoting haemostasis in a patient is provided by the administration, to the site of blood loss, of a viscous thixotropic haemostatic composition comprising an ionic precipitating agent, a fatty alcohol, an alcohol phosphate diester and one of an alkoxyether phosphate or a monoester phosphate of an alkoxylated fatty alcohol.Type: ApplicationFiled: September 12, 2013Publication date: August 27, 2015Applicant: Eupharma Pty LtdInventor: Malvin Eutick
-
Publication number: 20140141087Abstract: The invention provides an oral composition comprising a pharmaceutically acceptable carrier, at least one antacid, an inorganic matrix comprising at least silicon dioxide and titanium dioxide, and an anaesthetic, wherein the composition is substantially evenly dispersed in the carrier and is palatable.Type: ApplicationFiled: July 13, 2012Publication date: May 22, 2014Applicant: Eupharma Pty LtdInventor: Malvin Eutick
-
Publication number: 20130096123Abstract: The invention provides an oral liquid composition of a hypoxic radiation sensitiser comprising the radiation sensitiser in a concentration of greater than 5 mg/ml, and a method of treating a subject with a hypoxic condition comprising administration to the subject of a combination of a composition of the invention and radiation.Type: ApplicationFiled: April 14, 2011Publication date: April 18, 2013Applicant: EUPHARMA PTY LTDInventor: Malvin Leonard Eutick